Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the exchanges that its trading window will be closed starting January 1, 2026, until 48 hours after the company announces its Q3 FY2025-26 financial results (quarter ending December 31, 2025). During this period, company insiders and anyone in possession of unpublished price-sensitive information are prohibited from trading in the company's shares. This is a routine compliance measure under SEBI's insider trading regulations, typically observed before quarterly results are declared. The board meeting date to approve the Q3 results will be announced separately.
This is a standard regulatory compliance filing and does not have a direct impact on shareholders or stock price. Investors should watch for the upcoming Q3 FY26 results announcement, which is expected to follow once the board meeting date is disclosed.